- Home
- CRBU vs NOTE Comparison
CRBU vs NOTE Comparison
Compare CRBU & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- NOTE
- Stock Information
- Founded
- CRBU 2011
- NOTE 2013
- Country
- CRBU United States
- NOTE United States
- Employees
- CRBU N/A
- NOTE N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- NOTE EDP Services
- Sector
- CRBU Health Care
- NOTE Technology
- Exchange
- CRBU Nasdaq
- NOTE Nasdaq
- Market Cap
- CRBU 151.2M
- NOTE 169.3M
- IPO Year
- CRBU 2021
- NOTE N/A
- Fundamental
- Price
- CRBU $1.52
- NOTE $1.37
- Analyst Decision
- CRBU Strong Buy
- NOTE Strong Buy
- Analyst Count
- CRBU 5
- NOTE 6
- Target Price
- CRBU $11.80
- NOTE $3.30
- AVG Volume (30 Days)
- CRBU 1.6M
- NOTE 3.8M
- Earning Date
- CRBU 03-10-2025
- NOTE 03-11-2025
- Dividend Yield
- CRBU N/A
- NOTE N/A
- EPS Growth
- CRBU N/A
- NOTE N/A
- EPS
- CRBU N/A
- NOTE N/A
- Revenue
- CRBU $11,475,000.00
- NOTE $125,062,000.00
- Revenue This Year
- CRBU N/A
- NOTE N/A
- Revenue Next Year
- CRBU N/A
- NOTE $4.01
- P/E Ratio
- CRBU N/A
- NOTE N/A
- Revenue Growth
- CRBU N/A
- NOTE N/A
- 52 Week Low
- CRBU $1.50
- NOTE $0.75
- 52 Week High
- CRBU $8.33
- NOTE $2.27
- Technical
- Relative Strength Index (RSI)
- CRBU 34.82
- NOTE 58.95
- Support Level
- CRBU $1.50
- NOTE $0.98
- Resistance Level
- CRBU $1.69
- NOTE $1.37
- Average True Range (ATR)
- CRBU 0.13
- NOTE 0.16
- MACD
- CRBU -0.01
- NOTE 0.00
- Stochastic Oscillator
- CRBU 3.70
- NOTE 69.64
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.